<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Coughlan L</submitter><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><pagination>360-363</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7480642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(3)</volume><pubmed_abstract>In this issue of Cell Host &amp; Microbe, three papers describe the pseudotyping of vesicular stomatitis virus (VSV) with the SARS-CoV-2 spike. This VSV-CoV-2-S platform allows virus neutralization assays to be performed at BSL-2 and also has applications as a candidate vectored vaccine to elicit protective immunity against SARS-CoV-2.</pubmed_abstract><journal>Cell host &amp; microbe</journal><pubmed_title>Snatching the Crown from SARS-CoV-2.</pubmed_title><pmcid>PMC7480642</pmcid><funding_grant_id>R21 AI157606</funding_grant_id><funding_grant_id>R21 AI146529</funding_grant_id><pubmed_authors>Coughlan L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Snatching the Crown from SARS-CoV-2.</name><description>In this issue of Cell Host &amp; Microbe, three papers describe the pseudotyping of vesicular stomatitis virus (VSV) with the SARS-CoV-2 spike. This VSV-CoV-2-S platform allows virus neutralization assays to be performed at BSL-2 and also has applications as a candidate vectored vaccine to elicit protective immunity against SARS-CoV-2.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2025-04-05T07:22:29.469Z</modification><creation>2020-09-13T07:06:50Z</creation></dates><accession>S-EPMC7480642</accession><cross_references><pubmed>32910919</pubmed><doi>10.1016/j.chom.2020.08.007</doi></cross_references></HashMap>